Mymetics Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,816.30
3,186.10
2,265.50
419.20
1,708.80
1,140.80
Cost of Goods Sold (COGS) incl. D&A
26.60
-
-
-
-
-
Gross Income
5,789.70
-
-
-
-
-
SG&A Expense
2,717.60
3,877.20
3,647.20
2,494.50
3,727.80
2,751.20
EBIT
3,072.10
734.90
1,661.20
2,226.80
2,063.00
1,644.60
Unusual Expense
8,360.00
-
-
2,506.60
-
-
Non Operating Income/Expense
35.90
145.90
1,228.70
966.80
359.80
145.10
Interest Expense
3,437.20
3,462.00
2,854.40
2,846.20
2,929.20
3,109.80
Pretax Income
8,033.40
4,342.80
3,283.50
6,609.50
4,632.40
4,899.50
Income Tax
63.70
23.90
49.90
12.20
5.60
22.40
Consolidated Net Income
7,969.70
4,318.90
3,333.40
6,597.40
4,638.10
4,921.90
Net Income
7,969.70
4,318.90
3,333.40
6,597.40
4,638.10
4,921.90
Net Income After Extraordinaries
7,969.70
4,318.90
3,333.40
6,597.40
4,638.10
4,921.90
Net Income Available to Common
7,969.70
4,318.90
3,333.40
6,597.40
4,638.10
4,921.90
EPS (Basic)
0.03
0.01
0.01
0.02
0.01
0.02
Basic Shares Outstanding
295,384.60
302,280.30
303,757.60
303,757.60
303,757.60
303,757.60
EPS (Diluted)
0.03
0.01
0.01
0.02
0.02
0.02
Diluted Shares Outstanding
295,384.60
302,280.30
303,757.60
303,757.60
303,757.60
303,757.60
EBITDA
3,098.70
691.10
1,613.50
2,180.30
2,019.00
1,610.40
Other Operating Expense
-
-
231.80
105.10
-
-
Non-Operating Interest Income
2.70
-
3.30
3.30
-
-

About Mymetics

View Profile
Address
Route de la Corniche 4
Epalinges Vaud 1066
Switzerland
Employees -
Website http://www.mymetics.com
Updated 07/08/2019
Mymetics Corp. is a biotechnology company, which engages in the provision of research and development of vaccines for infectious and life threatening diseases. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland. .